Seeing Is Believing
Currently, out of the existing stock ratings of Biren Amin - 136 which are a Buy (83.95%), 25 which are a Hold (15.43%), 1 which are a Sell (0.62%)
Analyst Biren Amin works at JEFFERIES and is covering the Healthcare sector with 305 price targets and ratings displayed on 32 stocks.
Biren Amin's average stock forecast success ratio is 57.52% with an average time for price targets to be met of 205.79 days.
Most recent stock forecast was given on ALLO, Allogene Therapeutics at 01-Jul-2021.
Analyst best performing recommendations are on CCCC (C4 THERAPEUTICS).
The best stock recommendation documented was for ZYNE (ZYNERBA PHARMACEUTICALS) at 9/16/2019. The price target of $11 was fulfilled within 2 days with a profit of $0.51 (4.43%) receiving and performance score of 22.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
8.15
$7.02 (621.24%)
8.15
6 months 18 days ago
0/4 (0%)
$7.74 (289.82%)
Buy
8
$6.95 (661.90%)
11
1 years 7 months ago
1/4 (25%)
$4.85 (120.78%)
632
Buy
6.87
$5.74 (507.96%)
2 years 6 months 17 days ago
0/1 (0%)
$3.72 (118.10%)
Buy
7
$4.56 (186.89%)
6 years 5 months 12 days ago
0/2 (0%)
$4.6 (103.40%)
What Year was the first public recommendation made by Biren Amin?